Navigation Links
Insmed Announces Planned Departure Of Chief Financial Officer
Date:7/30/2012

MONMOUTH JUNCTION, N.J., July 30, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the lung, today announced that the Company's Executive Vice President & Chief Financial Officer, Kevin Tully, will be leaving the Company when his current contract expires on December 1, 2012 due to family reasons.  Insmed has begun its search to identify candidates to replace Mr. Tully in the CFO role. 

"I would like to thank Kevin for his considerable contributions to Insmed in the 11 years he has spent with the Company," said Timothy Whitten, Insmed's President and Chief Executive Officer. "He was instrumental in enabling the successful combination of Insmed and Transave, as well completing a number of other critical initiatives during his tenure.  We wish him well in all his future endeavors."

About Insmed

Insmed Incorporated is a biopharmaceutical company focused on the development of innovative inhaled pharmaceuticals for the site-specific treatment of serious lung diseases.  Insmed's primary focus is on the development of inhaled antibiotic therapy delivered via proprietary advanced liposomal pulmonary technology in areas of high unmet need.  For more information, please visit http://www.insmed.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to Mr. Tully's departure and the search for his replacement constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, delays in
'/>"/>

SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Insmed to Host 2012 Second Quarter Earnings Conference Call
2. Insmed To Present At JMP Securities 7th Annual Healthcare Conference
3. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
4. Insmed Announces First Quarter 2012 Financial Results
5. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
6. Insmed to Host 2012 First Quarter Earnings Conference Call
7. Absorption Systems announces novel test platform for interactions with the BCRP transporter
8. Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares
9. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
10. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
11. Gentris Corporation Announces Collaboration to Study Blood Stability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Eli Lilly and Company (NYSE: ... scams, purportedly using the name of the company and/or ... the public through postal mail solicitations and job-seekers through ... any foreign lottery organizations and do not conduct the ... of the scam. The activities described in these scams ...
(Date:6/19/2013)... , June 19, 2013   NextDocs announced ... service clinical research organization, at DIA 2013 , ... companies will present case studies that explore best practices ... to electronic trial master file (eTMF) systems. ... will present alongside Krystyna Kowalczyk , executive vice ...
(Date:6/19/2013)... , June 19, 2013   BioCision ... sample standardization and handling in many areas of ... of new patents by the U.S. Patent Office ... products developed to standardize sample handling to ensure ... results in common laboratory procedures. ...
Breaking Medicine Technology:Lilly Issues Alert for Illegal Scams Involving Fraudulent Checks and Online Job Requests 2NextDocs and Novella to Present on eTMF at DIA 2013 2BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2
... 2012 Mylan Inc. (Nasdaq: MYL ) ... received final approval from the U.S. Food and Drug ... for Fluvastatin Capsules USP, 20 mg and 40 mg, ... Capsules. This product is indicated for the treatment of ...
... Maine, April 12, 2012 Expanding on the ... devices, Puritan Medical Products Co. LLC launches two ... use through its newly created division, Puritan Diagnostics ... Our universal transport media system has ...
Cached Medicine Technology:Mylan Launches First Generic Version of Lescol® Capsules 2Puritan Medical Products Company Launches New Diagnostic Collection and Transport Systems 2
(Date:6/19/2013)... international study led by researchers at The University of ... continues to show remarkable promise for the treatment of ... most recent interim findings of the 18-center Phase 2 ... Journal of Medicine . Previous interim findings were presented ... Hematology Annual Meeting and Exposition. , Unprecedented ...
(Date:6/19/2013)... Children had half as many emergency department visits ... on five or more days a week, according to ... Children,s Hospital and Johns Hopkins University. , The new ... Journal of Pediatrics and will be presented at ... an important step in understanding where primary care practices ...
(Date:6/19/2013)... -- Nearly 70 percent of Americans are ... than half take two, Mayo Clinic researchers say. ... prescribed, their study found. Twenty percent of patients ... to the findings, published online in the journal ... For audio and video of Dr. Jennifer St. ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 North ... announced organizational changes to advance development of its ... said, “To support the advanced development of our ... changes to the Company’s management structure and engaged ... The Company announced that Michael Galiger will serve ...
(Date:6/19/2013)... Atlanta, Ga (PRWEB) June 19, 2013 ... billing and business management software solutions for the post-acute care ... position 79 - on the Healthcare Informatics 100 (HCI ... healthcare IT companies in the U.S. in terms of revenue ... grown at an average rate of 85% annually, and the ...
Breaking Medicine News(10 mins):Health News:Ibrutinib continues strong showing against mantle cell lymphoma 2Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Nearly 7 in 10 Americans are on prescription drugs, Mayo Clinic study finds 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 2Health News:Entegrion Announces Organizational Changes to Support Advanced Product Development 3Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3
... million commitment from James H. and Marilyn H. Simons ... as part of Memorial Sloan-Ketterings new Brain Tumor Center ... to achieve fundamental new insights into the molecular and ... plan to apply that knowledge to the creation of ...
... of Lifetime,s Nonpartisan Every Woman Counts Election Year, ... Issues That Matter Most -, NEW YORK, Feb. ... Heart Month, Lifetime Television launches its third annual Don,t,Skip ... the nation,s leading women,s health experts, the Network offers,a ...
... - The field of presidential contenders dwindled Wednesday when ... John Edwards (D-N.C.) dropped out of the race. ... frontrunners will continue to face a formidable challenge from ... season will intensify this weekend as the candidates visit ...
... Feb. 1 While winter,s harsh, windy weather,is often ... of lip,irritation is harder to pinpoint. In fact, several ... have been linked to dry lips. The,key is determining ... to eliminate the problem., Speaking today at the ...
... International Associates, Inc,administrator for the HealthShares(TM) Indexes, a ... Funds, today announced,that effective at the opening of ... ALOG ) will replace Ventana Medical Systems,Inc. ... Index. Ventana,s is,being acquired by Roche group based ...
... ALLEGAN, Mich., Feb. 1 The Perrigo Company,(Nasdaq: ... Board of Directors has,authorized the repurchase of $150 ... 2010 under its ongoing share repurchase program. Any,remaining ... on,February 8, 2009. Under share repurchase programs since ...
Cached Medicine News:Health News:Simons Foundation grant boosts brain tumor research 2Health News:Lifetime Television Launches Third Annual Don't Skip a Beat Multi-Platform Heart Health Awareness Initiative 2Health News:Lifetime Television Launches Third Annual Don't Skip a Beat Multi-Platform Heart Health Awareness Initiative 3Health News:Election 2008: Sleep deprivation a tough opponent for presidential candidates 2Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 2Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 3Health News:Don't Pout About Irritated Lips: Dermatologists Can Offer Top Tips to Help Keep Lips in Tip-Top Shape 4
Inquire...
Hush Puppies Pups feature vibrant colors and playful styling for children. Kids love the added comfort while parents love the durable designs found in every Hush Puppies Pups frame....
... Recognized for classic styling, Tura's original collection ... with discriminating taste. Tura designs exemplify the ... and style with quality and durability. The ... set the Tura woman apart. Rich colors ...
... The collection features a variety of ... array of feminine styles designed with ... both men and women that are ... materials as used in our fine ...
Medicine Products: